Minova Life Science

Minova life sciences - Pharmaceutical company

Diazero-PM Tablets

COMPOSITION – Glimepiride IP 2mg + Metformin Hydrochloride IP 500 mg (S.R.) +Pioglitazone Hcl IP 15 mg


-A thiazolidinedione that has established efficacy in improving glycaemic control in patients with type 2 diabetes.

• Improved insulin resistance and glycemic control, as well as TG and high-density lipoprotein-cholesterol [HDL-C) and may help reduce cardiovascular risk for patients with type 2 diabetes.

• Effective in reducing blood glucose in patients with newly diagnosed Type 2 diabetes.

Explore other products

Scroll to Top